Literature DB >> 24680563

Paradoxical reaction in HIV negative tuberculous meningitis.

Ravindra Kumar Garg1, Hardeep Singh Malhotra2, Neeraj Kumar2.   

Abstract

This review focusses on paradoxical reactions occurring during the treatment of tuberculous meningitis (TBM) in human immunodeficiency virus-negative cases. A paradoxical reaction is defined as the worsening of a pre-existing lesion or the appearance of new lesion in a patient whose clinical symptoms initially improved with anti-tuberculosis treatment. A number of different paradoxical reactions have been reported in patients with TBM including expansion of existing cerebral tuberculomas, and appearance of new tuberculomas, hydrocephalus, and optochiasmatic and spinal arachnoiditis. While the exact mechanism of paradoxical reactions is uncertain, an exaggerated immune reaction against Mycobacterium tuberculosis-associated antigens is currently the most accepted theory for tuberculous paradoxical reaction. Corticosteroids are considered to have a beneficial effect in the management of paradoxical reactions. Immuno-modulatory drugs, including tumor necrosis factor-α antagonists, thalidomide and interferon-γ have been used in isolated cases with more severe forms of paradoxical reactions.
Copyright © 2014 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Central nervous system; Corticosteroids; Hydrocephalus; Mycobacterium tuberculosis; Tuberculoma; Tuberculosis

Mesh:

Substances:

Year:  2014        PMID: 24680563     DOI: 10.1016/j.jns.2014.03.025

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  27 in total

1.  Treatment-Associated Inflammatory Deterioration in Tuberculous Meningitis: Unpicking the Paradox.

Authors:  Nguyen Thuy Thuong Thuong; Guy E Thwaites
Journal:  J Infect Dis       Date:  2017-03-01       Impact factor: 5.226

Review 2.  Neurotuberculosis: an update.

Authors:  Ajith Cherian; Kesi Chellappan Ajitha; Thomas Iype; K P Divya
Journal:  Acta Neurol Belg       Date:  2021-01-05       Impact factor: 2.396

Review 3.  Spinal cord involvement in tuberculous meningitis.

Authors:  R K Garg; H S Malhotra; R Gupta
Journal:  Spinal Cord       Date:  2015-04-21       Impact factor: 2.772

4.  Neurotuberculosis: Control of Steroid-Refractory Paradoxical Inflammatory Reaction With Ruxolitinib.

Authors:  Yingda L Xie; Fanny Ita-Nagy; Ray Y Chen; Maura M Manion; Irini Sereti; Luxin Pei; Steven M Holland
Journal:  Open Forum Infect Dis       Date:  2019-10-26       Impact factor: 3.835

5.  Intractable Tuberculous Meningitis With Paradoxical Reactions Treated by Anti-Tissue Necrosis Factor-α Therapy.

Authors:  Keon-Woo Kim; Hyo Jae Kim; Hyun-Woo Kim; Sung-Han Kim; Sang Ahm Lee; Yong Seo Koo
Journal:  Neurol Clin Pract       Date:  2021-08

6.  Paroxysmal sympathetic hyperactivity syndrome in tuberculous meningitis with paradoxical reaction.

Authors:  Andre Marolop Pangihutan Siahaan; Steven Tandean; Rr Suzy Indharty; Bahagia Willibrodus Maria Nainggolan; Martin Susanto
Journal:  Int J Surg Case Rep       Date:  2022-09-08

Review 7.  Paradoxical manifestations during tuberculous meningitis treatment among HIV-negative patients: a retrospective descriptive study and literature review.

Authors:  Rogelio Domínguez-Moreno; Miguel García-Grimshaw; David Medina-Julio; Carlos Cantú-Brito; Alejandra González-Duarte
Journal:  Neurol Sci       Date:  2021-10-27       Impact factor: 3.830

Review 8.  Tuberculosis Meningitis.

Authors:  Kassem Bourgi; Christina Fiske; Timothy R Sterling
Journal:  Curr Infect Dis Rep       Date:  2017-09-11       Impact factor: 3.725

9.  Spinal cord and spinal nerve root involvement (myeloradiculopathy) in tuberculous meningitis.

Authors:  Rahul Gupta; Ravindra Kumar Garg; Amita Jain; Hardeep Singh Malhotra; Rajesh Verma; Praveen Kumar Sharma
Journal:  Medicine (Baltimore)       Date:  2015-01       Impact factor: 1.889

Review 10.  Diagnosis and treatment of extrapulmonary tuberculosis.

Authors:  Ji Yeon Lee
Journal:  Tuberc Respir Dis (Seoul)       Date:  2015-04-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.